CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale President and CEO sold 21,353 shares at $8.96 ($191,323)
- 4 Open-market sale SVP, CFO, Sec & Treasurer sold 9,564 shares at $8.96 ($85,693)
- 4 Open-market sale SVP & Chief Medical Officer sold 12,380 shares at $8.96 ($110,925)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 11,170 shares at $8.97 ($100,156)
- 4/A Open-market buy 10% owner bought 425,982 shares at an average $8.60 ($3,665,308)
- 4 Open-market buy 10% owner bought 1,201,364 shares at an average $8.38 ($10,063,274)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 131,739 shares at an average $12.68 ($1,670,486)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 29 · 579 filings